REFERENCES
- Muschter R, de la Rosette JJ, Whitfield H, Pellerin JP, Madersbacher S. Gillatt D. Initial human clinical experience with diode laser interstitial treatment of benign prostatic hyperplasia. Urology 1996; 48: 223–8.
- Muschter R, Hessel S. Hofstetter A, Keiditsch E, Rothenberger K-H, Schneede P. et al. Interstitial laser coagulation of benign prostatic hyperplasia. Urologe 1993; 32: 273–81 [in German].
- Razvi HA, Muschter R, Anson K, Vargas JC, Perlmutter AP. Alteration of laser-tissue interaction with the 805 nm diode laser using indocyanine green in the canine prostate. Lasers Surg Med 1996; 19: 184–9.
- Perlmutter AP, Muschter R. Interstitial laser prostatec-tomy. Mayo Clin Proc 1998; 73: 903–7.
- Dixon CM. Lasers for the treatment of benign prostatic hyperplasia. Urol Clin North Am 1995; 22: 413–22.
- Mueller-Lisse UG, Heuck AF, Schneede P. Muschter R, Scheidler J, Hofstetter AG, et al. Postoperative MRI in patients undergoing interstitial laser coagulation ther-motherapy of benign prostatic hyperplasia. J Comput Assist Tomogr 1996; 20: 273–8.
- Muschter R, Hofstetter A. Technique and results of interstitial laser coagulation. World J Urol 1995; 14: 109–14.
- Daehlin L, Mohn J, Hoisaeter PA, Hedlund H, Kapstad L, Moen G, et al. Interstitial laser coagulation in the treatment of benign prostatic hyperplasia. Preliminary results. Tidsskr Nor Laegeforen 1997; 117: 3790–3.
- De la Rosette JJ, Muschter R, Lopez MA, Gillat D. Interstitial laser coagulation in the treatment of benign prostatic hyperplasia using diode-laser system with temperature feedback. Br J Urol 1997; 80: 433–8.
- Fabian KM. Der intraprostatische Tartielle Katheter' (Urologische Spirale). Urologe A 1980; 19: 236–8.
- Tät-maid P. Biodegradable self-reinforced composite materials: manufacturing structure and mechanical properties. Clin Mater 1992; 10: 29–43.
- Kemppainen E, Talja M, Riiheld M, Pohjonen T, Tät-maid P. Alfthan O. A bioresorbable urethral stent. Urol Res 1993; 21: 235–8.
- Talja M, Tammela T, Petas A, Välimaa T, Taari K, Viherkoski E, et al. Biodegradable self-reinforced polyglycolic acid spiral stent in prevention of post-operative urinary retention after visual laser ablation of the prostate-laser prostatectomy. J Urol 1995; 154: 2089–92.
- Hald T, Nordling J, Andersen JT, Bilde T, Meyhoff HH, Walter S. A patient weighted symptom score system in the evaluation of uncomplicated benign prostatic hyperplasia. Scand J Urol Nephrol Suppl 1991; 138: 59–62.
- Zlotta AR, Raviv G, Peny MO, Noel JC, Haot J, Schulman CC. Possible mechanisms of action of transurethral needle ablation of the prostate on benign prostatic hyperplasia symptoms: a neurohistochemical study. J Urol 1997; 157: 894–9.
- Dahlstrand C, Grundtman S, Pettersson S. High-energy transurethral microwave thermotherapy for large se-verely obstructing prostates and the use of biodegrad-able stents to avoid catheterization after treatment. Br J Urol 1997; 79: 907–9.
- Petas A, Talja M, Tammela TLJ, Taari K, Välimaa T, Tät-maid P. The biodegradable self-reinforced poly-DL-lactic acid spiral stent compared with a suprapubic catheter in the treatment of post-operative urinary retention after visual laser ablation of the prostate. Br J Urol 1997; 80: 439–43.